Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Thien

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Experimental Hematology|December 24, 2014
Loss of c-Cbl E3 ubiquitin ligase activity enhances the development of myeloid leukemia in FLT3-ITD mutant miceSamuel J Taylor, Christine B F Thien, Samantha A Dagger, et al.
Nature Immunology|July 15, 2009
A TNF- and c-Cbl-dependent FLIP(S)-degradation pathway and its function in Mycobacterium tuberculosis-induced macrophage apoptosisManikuntala Kundu, Sushil Kumar Pathak, Kuldeep Kumawat, et al.
Allergy|December 28, 2016
Breast milk polyunsaturated fatty acids: associations with adolescent allergic disease and lung functionN T Waidyatillake, R Stoney, F Thien, et al.
The Journal of Clinical Investigation|November 3, 2004
c-Cbl-deficient mice have reduced adiposity, higher energy expenditure, and improved peripheral insulin actionJuan C Molero, Thomas E Jensen, Phil C Withers, et al.
The Lancet. Respiratory Medicine|October 3, 2025
Taladegib for the treatment of idiopathic pulmonary fibrosis (ENV-IPF-101): a multicentre, randomised, double-blind, placebo-controlled, phase 2a trialT M Maher, J G Goldin, J Hood, et al.
Internal Medicine Journal|June 29, 2016
Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair RegistryP G Gibson, H Reddel, V M McDonald, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 6, 2016
Real-life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteriaM Hew, A Gillman, M Sutherland, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 21, 2018
Working while unwell: Workplace impairment in people with severe asthmaS A Hiles, E S Harvey, V M McDonald, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Experimental Hematology|December 24, 2014
Loss of c-Cbl E3 ubiquitin ligase activity enhances the development of myeloid leukemia in FLT3-ITD mutant miceSamuel J Taylor, Christine B F Thien, Samantha A Dagger, et al.
Nature Immunology|July 15, 2009
A TNF- and c-Cbl-dependent FLIP(S)-degradation pathway and its function in Mycobacterium tuberculosis-induced macrophage apoptosisManikuntala Kundu, Sushil Kumar Pathak, Kuldeep Kumawat, et al.
Allergy|December 28, 2016
Breast milk polyunsaturated fatty acids: associations with adolescent allergic disease and lung functionN T Waidyatillake, R Stoney, F Thien, et al.
The Journal of Clinical Investigation|November 3, 2004
c-Cbl-deficient mice have reduced adiposity, higher energy expenditure, and improved peripheral insulin actionJuan C Molero, Thomas E Jensen, Phil C Withers, et al.
The Lancet. Respiratory Medicine|October 3, 2025
Taladegib for the treatment of idiopathic pulmonary fibrosis (ENV-IPF-101): a multicentre, randomised, double-blind, placebo-controlled, phase 2a trialT M Maher, J G Goldin, J Hood, et al.
Internal Medicine Journal|June 29, 2016
Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair RegistryP G Gibson, H Reddel, V M McDonald, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 6, 2016
Real-life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteriaM Hew, A Gillman, M Sutherland, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 21, 2018
Working while unwell: Workplace impairment in people with severe asthmaS A Hiles, E S Harvey, V M McDonald, et al.
Pageof 7